{"id":"W4412479874","doi":"10.1016/j.annonc.2025.05.496","title":"479MO Phase I/II clinical investigation of invikafusp alfa, a first-in-class TCR-beta chain-targeted bispecific antibody, as monotherapy in patients with anti-PD(L)1-resistant, antigen-rich gastrointestinal (GI) cancers","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Antibody; T-cell receptor; Antigen; Bispecific antibody; BETA (programming language); Oncology; Immunology; Cancer research; T cell; Immune system; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006665317,0.0008983818,0.001060587,0.000318519,0.0003176326,0.0007523728,0.0004849542,0.0008088779,0.003960407],"category_scores_gemma":[0.0002952787,0.0003617885,0.000887687,0.0002237383,0.0004862505,0.0004677334,0.000192595,0.002194769,0.001088695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006599539,"about_ca_system_score_gemma":0.001102113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001298496,"about_ca_topic_score_gemma":0.004219765,"domain_scores_codex":[0.9998447,0.00005076958,0.000005222104,0.00002037545,0.0000140965,0.00006485495],"domain_scores_gemma":[0.9998313,0.00001926882,0.00001909139,0.000013109,0.00001404043,0.0001031575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3827497,0.05484636,0.008535269,0.001639173,0.002252033,0.0005825491,0.0005781601,0.007388352,0.1538688,0.001881729,0.02570593,0.3599721],"study_design_scores_gemma":[0.3925821,0.5384874,0.02036827,0.0001651153,0.001062733,0.000849647,0.0001902793,0.004966335,0.01744669,0.0009265337,0.02288573,0.00006912916],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801896,0.005586357,0.001168066,0.0009989984,0.0002972444,0.001743516,0.002222947,0.0003282677,0.007464978],"genre_scores_gemma":[0.9801217,0.003971844,0.001997139,0.001406985,0.0001269649,0.001392828,0.003955097,0.00005869812,0.006968637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003960407,"threshold_uncertainty_score":0.01324886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06488600984547917,"score_gpt":0.4213885211849206,"score_spread":0.3565025113394414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}